Survey: Preferences for deprescribing antihypertensive medicines for people living with dementia

Survey: Preferences for deprescribing antihypertensive medicines for people living with dementia

The School of Public Health, University of Sydney, invites you to participate in a study survey which aims to understand stakeholder clinician preferences for potential benefits and harms of deprescribing antihypertensives for people living with dementia, to estimate the relative importance of different consequences in clinical decision making. Your experience and opinions on deprescribing would provide a valuable insight into clinician preferences for deprescribing options for people living with dementia.

The survey will take approximately 20-30 minutes to complete. Your individual response will be confidential. Your identity as a participant will remain anonymous.

If you have any concerns or complaints about the ethical conduct of the research project, you may contact the Ethics Administration Manager, University of Sydney +61 2 8627 8176 human.ethics@sydney.edu.au (Study number 2021/804).

Please note that completion and submission of this survey means that you consent to participate in this study.

Complete the online survey here.